Eris Lifesciences has executed a share purchase agreement with Rakesh Dhuria, a promoter of Kinedex Healthcare, with the intent of increasing its ownership and control of the said subsidiary i.e. Kinedex by way of purchase of 12,239 equity shares of face value of Rs 10 each (equivalent to 6.71%).
Prior to this transaction, the company (including its nominees) held 75.48% shareholding in Kinedex. Post completion of this transaction, the total holding of the company (including its Nominees) shall stand at 82.19% (rounded to two decimal places).
Eris Lifesciences is engaged in manufacturing, marketing and selling of branded generics within the chronic and acute categories of the Indian Pharmaceutical Market.